Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Merdad Parsey Insider Profile
4 Followers
Merdad Parsey, CMO at Gilead Sciences, holds 82.85K shares in Gilead Sciences (Ticker: GILD), holds 12.79K shares in Sagimet Biosciences, Inc. Class A (Ticker: SGMT).
Merdad Parsey has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Merdad Parsey holds in companies
Most Profitable Insider Trade
The most profitable trade made by Merdad Parsey
Merdad Parsey's Trading History
Gilead Sciences
Dec 11, 2024
CMO
Uninformative Buy
189.20K
$7.67M
Sagimet Biosciences, Inc. Class A
Jul 20, 2023
Director
Uninformative Buy
―
$63.33K
List of latest transactions for each holding click on a transaction to see Merdad Parsey's performance on stock
You May Also Like
Merdad Parsey insider profile FAQ
What is the percentage of profitable transactions made by Merdad Parsey?
The percentage of profitable transactions made by Merdad Parsey is ―.
What is the average return per transaction made by Merdad Parsey?
The average return per transaction made by Merdad Parsey is ―.
What stocks does Merdad Parsey hold?
Merdad Parsey holds: GILD, SGMT stocks.
What was Merdad Parsey’s latest transaction?
Merdad Parsey latest transaction was an Uninformative Buy of $189.20K.
What was Merdad Parsey's most profitable transaction?
Merdad Parsey’s most profitable transaction was an Informative Sell of GILD stock on November 29, 2024. The return on the trade was 0.40%.
What is Merdad Parsey's role in Gilead Sciences?
Merdad Parsey's role in Gilead Sciences is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.